NCT06684106View on ClinicalTrials.gov

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

NARecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

November 11, 2026

Study Completion Date

June 1, 2027

Conditions
HyperlipidemiaUrsodeoxycholic AcidStatin TherapyGlucose Intolerance
Interventions
DRUG

Ursodeoxycholic acid (UDCA) 500 mg

UDCA together with statin in eligible participants

DRUG

Placebo

placebo together with statin in ASCVD patients

Trial Locations (2)

710061

RECRUITING

Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Unknown

RECRUITING

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER